---
figid: PMC3678929__rmmj_2-2-e0043f2
figlink: /pmc/articles/PMC3678929/figure/f2-rmmj_2-2-e0043/
number: F2
caption: Insulin-like growth factor 1 receptor (IGF-1R) signaling pathway. Binding
  of IGF-1 or IGF-2 or insulin to the IGF-1R α-subunit leads to autophosphorylation
  of β-subunit residues, which then act as docking site to insulin receptor substrates
  (IRS-1 to 4). IRS-1 recruits the p85 regulatory subunit of phosphatidylinositol
  3-kinase (PI3K) which activates the p110 catalytic subunit, then resulting in the
  formation of phosphatidylinositol 3,4 phosphate (PIP2) and phosphatidylinositol
  3,4,5 phosphate (PIP3). PIP3 activates Akt. Activated Akt has many substrates; in
  one pathway Akt inhibits apoptosis by inactivating BCL-2 antagonist of cell death
  (BAD), and in the second pathway Akt regulates protein synthesis by phosphorylating
  tuberous sclerosis complex (TSC1/2). This phosphorylation removes the inhibition
  of TSC1/2 from mammalian target of rapamycin (mTOR). mTOR activates the ribosomal
  S6 kinase (S6K) and eukaryotic initiation factor 4E-binding protein-1 (4E-BP-1),
  leading to protein synthesis. In the absence of cellular nutrients, AMPK can inhibit
  protein synthesis through mTOR inhibition, both directly and by activating the TSC1/2
  complex. The tumor suppressor phosphates and tensin homolog deleted on chromosome
  10 (PTEN) inhibits PI3K. The mitogen-activated protein kinase (MAPK) pathway can
  also be activated by IGF-1R activation. In this pathway IGF-1R activates the adaptor
  proteins, She and Grb2, leading to activation of Ras, Raf, MEK1/2, and ERK1/2, which
  results in cell proliferation.
pmcid: PMC3678929
papertitle: The Role of Insulin and Insulin-like Growth Factors in the Increased Risk
  of Cancer in Diabetes.
reftext: Derek LeRoith, et al. Rambam Maimonides Med J. 2011 Apr;2(2):e0043.
pmc_ranked_result_index: '1773'
pathway_score: 0.9577923
filename: rmmj_2-2-e0043f2.jpg
figtitle: Insulin-like growth factor 1 receptor (IGF-1R) signaling pathway
year: '2011'
organisms: Homo sapiens
ndex: 7fcc8c69-dee5-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3678929__rmmj_2-2-e0043f2.html
  '@type': Dataset
  description: Insulin-like growth factor 1 receptor (IGF-1R) signaling pathway. Binding
    of IGF-1 or IGF-2 or insulin to the IGF-1R α-subunit leads to autophosphorylation
    of β-subunit residues, which then act as docking site to insulin receptor substrates
    (IRS-1 to 4). IRS-1 recruits the p85 regulatory subunit of phosphatidylinositol
    3-kinase (PI3K) which activates the p110 catalytic subunit, then resulting in
    the formation of phosphatidylinositol 3,4 phosphate (PIP2) and phosphatidylinositol
    3,4,5 phosphate (PIP3). PIP3 activates Akt. Activated Akt has many substrates;
    in one pathway Akt inhibits apoptosis by inactivating BCL-2 antagonist of cell
    death (BAD), and in the second pathway Akt regulates protein synthesis by phosphorylating
    tuberous sclerosis complex (TSC1/2). This phosphorylation removes the inhibition
    of TSC1/2 from mammalian target of rapamycin (mTOR). mTOR activates the ribosomal
    S6 kinase (S6K) and eukaryotic initiation factor 4E-binding protein-1 (4E-BP-1),
    leading to protein synthesis. In the absence of cellular nutrients, AMPK can inhibit
    protein synthesis through mTOR inhibition, both directly and by activating the
    TSC1/2 complex. The tumor suppressor phosphates and tensin homolog deleted on
    chromosome 10 (PTEN) inhibits PI3K. The mitogen-activated protein kinase (MAPK)
    pathway can also be activated by IGF-1R activation. In this pathway IGF-1R activates
    the adaptor proteins, She and Grb2, leading to activation of Ras, Raf, MEK1/2,
    and ERK1/2, which results in cell proliferation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SHC3
  - KRAS
  - PRKAA2
  - PRKAB2
  - SHC2
  - PRKAA1
  - PRKAG3
  - AKT1
  - MAPK3
  - PRKAB1
  - PRKAG2
  - SHC1
  - PIK3CB
  - NRAS
  - AKT2
  - AKT3
  - PRKAG1
  - SHC4
  - MAPK1
  - SART3
  - HRAS
  - MAP2K2
  - TSC1
  - BAD
  - PIK3CA
  - PIK3R4
  - EIF4EBP1
  - BRAF
  - MAP2K1
  - PIK3R5
  - PIK3CD
  - MTOR
  - PIK3R6
  - PTEN
  - ARAF
  - PIK3CG
  - ELL
  - TSC2
  - RAF1
  - IRS1
  - PIK3R3
  - IGF2
  - GRB2
  - IGF1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: P110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: TSC1
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: 4E-BP-1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: ell
  symbol: ELL
  source: hgnc_symbol
  hgnc_symbol: ELL
  entrez: '8178'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: IGF-2
  symbol: IGF-II
  source: hgnc_alias_symbol
  hgnc_symbol: IGF2
  entrez: '3481'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3678929__F2
redirect_from: /figures/PMC3678929__F2
figtype: Figure
---
